U.S. stocks closed: Powell suppressed rate cut expectations, the three major indexes accelerated their decline in the last minutes.
1. China concept stocks were generally down, with the Nasdaq Golden Dragon Index falling by 1.81%; 2. The Trump transition team is planning to cancel the $7,500 tax credit for electric autos; 3. Ford was fined $0.165 billion for failing to comply with recall requests; 4. Blackrock aggressively bought Apple in Q3 and continued to increase its shareholding in the 'Big Seven' companies.
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
Vaccine-maker Stocks Like Moderna, Pfizer Drop as Trump Picks RFK Jr. to Lead HHS
Market Falls Thursday, Powell Said Fed Will Take Things Slow | Wall Street Today
Moderna, Pfizer Stocks Fall After Reports of RFK Jr. Nomination -- WSJ
Wolfe Research Downgrades Pfizer(PFE.US) to Sell Rating, Announces Target Price $25
Pfizer Options Spot-On: On November 14th, 282.25K Contracts Were Traded, With 3.22 Million Open Interest
Pfizer Initiated With an Underperform at Wolfe Research
Express News | Viking Fund Management 13F Shows Increased Stake In Broadcom From 16,510 To 162,100 Shares; Xcel Energy From 122,400 To 162,400 Shares; Chevron From 58,000 To 70,000 Shares; Starbucks From 87,000 To 105,000 Shares; Lam Research From 4,000 To 10,000...
Express News | Donald Trump Jr. Posts On X "Robert F Kennedy Jr Will Be The Secretary of Health and Human Services! Promises Made Promises Kept"
Express News | Pfizer Inc Drops in Volume Spike, Loast Down 3.0%
Shares of Vaccine Stocks Are Trading Lower Following a Report Suggesting President-elect Trump Is Expected to Nominate Robert F. Kennedy Jr. to Lead the HHS.
'Trump Expected To Select Robert F. Kennedy Jr. To Lead HHS; The Choice Will Roil Many Public Health Experts After His Years Of Touting Debunked Claims That Vaccines Cause Autism' - Politico
5 Healthcare Stocks to Buy in a Beaten-Up Sector -- Barrons.com
Thursday Market Chills From Election Celebration | Live Stock
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
UBS Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $31
UBS Remains a Hold on Pfizer (PFE)
Is Pfizer Inc. (PFE) Among The Top Dividend Contenders Right Now?
Pfizer Inc. (PFE) UBS Global Healthcare Conference (Transcript)